These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27146828)

  • 1. Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa.
    Evans D; Berhanu R; Moyo F; Nguweneza A; Long L; Fox MP
    AIDS Behav; 2016 Nov; 20(11):2717-2728. PubMed ID: 27146828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social and behavioral factors associated with failing second-line ART - results from a cohort study at the Themba Lethu Clinic, Johannesburg, South Africa.
    Evans D; Dahlberg S; Berhanu R; Sineke T; Govathson C; Jonker I; Lönnermark E; Fox MP
    AIDS Care; 2018 Jul; 30(7):863-870. PubMed ID: 29463102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa.
    Hanrahan CF; Schwartz SR; Mudavanhu M; West NS; Mutunga L; Keyser V; Bassett J; Van Rie A
    PLoS Med; 2019 May; 16(5):e1002808. PubMed ID: 31112543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
    Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
    AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of a Brief, Active Visualisation Intervention to Improve Adherence to Antiretroviral Therapy in Non-adherent Patients in South Africa.
    Jones ASK; Coetzee B; Kagee A; Fernandez J; Cleveland E; Thomas M; Petrie KJ
    AIDS Behav; 2019 Aug; 23(8):2121-2129. PubMed ID: 30259346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.
    Court R; Leisegang R; Stewart A; Sunpath H; Murphy R; Winternheimer P; Ally M; Maartens G
    BMC Infect Dis; 2014 Dec; 14():664. PubMed ID: 25472544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
    Fatti G; Mothibi E; Shaikh N; Grimwood A
    AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa.
    Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
    AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.
    Evans D; Hirasen K; Berhanu R; Malete G; Ive P; Spencer D; Badal-Faesen S; Sanne IM; Fox MP
    AIDS Res Ther; 2018 Apr; 15(1):10. PubMed ID: 29636106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
    Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
    Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa.
    Tsondai PR; Wilkinson LS; Grimsrud A; Mdlalo PT; Ullauri A; Boulle A
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21649. PubMed ID: 28770595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated HIV care in South Africa: the effect of fast-track treatment initiation counselling on ART initiation and viral suppression as partial results of an impact evaluation on the impact of a package of services to improve HIV treatment adherence.
    Pascoe SJ; Fox MP; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
    J Int AIDS Soc; 2019 Nov; 22(11):e25409. PubMed ID: 31691521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.
    Orrell C; Cohen K; Mauff K; Bangsberg DR; Maartens G; Wood R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):495-502. PubMed ID: 26218411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol: Strengthening understanding of effective adherence strategies for first-line and second-line antiretroviral therapy (ART) in selected rural and urban communities in South Africa.
    Gumede SB; de Wit JBF; Venter WDF; Lalla-Edward ST
    PLoS One; 2021; 16(12):e0261107. PubMed ID: 34932588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.